Abstract |
Respiratory syncytial virus (RSV) is an important cause of severe lower respiratory tract illness in infants and the elderly. Presently, no safe and efficacious RSV vaccine exists; however, advances in our understanding of immunity and the pathogenesis of disease associated with RSV infection may lead to new vaccine strategies. RSV G protein contains a CX3C chemokine motif that interacts with the CX3CR1 chemokine receptor and modifies the activities of fractalkine. In the present study, we show that anti-RSV G protein antibody responses after recent RSV infection or vaccination are associated with inhibition of RSV G protein CX3C-CX3CR1 interaction and RSV G protein-mediated leukocyte chemotaxis.
|
Authors | Jennifer L Harcourt, Ruth A Karron, Ralph A Tripp |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 190
Issue 11
Pg. 1936-40
(Dec 01 2004)
ISSN: 0022-1899 [Print] United States |
PMID | 15529257
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antibodies, Viral
- CX3C Chemokine Receptor 1
- CX3CL1 protein, human
- CX3CR1 protein, human
- Chemokine CX3CL1
- Chemokines, CX3C
- Membrane Proteins
- Receptors, Chemokine
- Respiratory Syncytial Virus Vaccines
- Vaccines, Attenuated
- Viral Proteins
|
Topics |
- Adult
- Antibodies, Viral
(analysis, biosynthesis)
- Binding Sites, Antibody
- CX3C Chemokine Receptor 1
- Chemokine CX3CL1
- Chemokines, CX3C
(chemistry, immunology)
- Chemotaxis, Leukocyte
- Child, Preschool
- Humans
- Infant
- Leukocytes
(immunology)
- Membrane Proteins
(immunology)
- Receptors, Chemokine
(immunology)
- Respiratory Syncytial Virus Infections
(immunology, prevention & control, virology)
- Respiratory Syncytial Virus Vaccines
(administration & dosage, immunology)
- Respiratory Syncytial Virus, Human
(immunology)
- Vaccination
- Vaccines, Attenuated
(administration & dosage, immunology)
- Viral Proteins
(antagonists & inhibitors, chemistry, immunology)
|